Diet-Induced Adipose Tissue Inflammation and Liver Steatosis Are Prevented by DPP-4 Inhibition in Diabetic Mice
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Diet composition alters the metabolic states of adipocytes and hepatocytes in diabetes. The effects of dipeptidyl peptidase-4 (DPP-4) inhibition on adipose tissue inflammation and fatty liver have been obscure. We investigated the extrapancreatic effects of DPP-4 inhibition on visceral fat and the liver. RESEARCH DESIGN AND METHODS: We investigated diet-induced metabolic changes in β-cell–specific glucokinase haploinsufficient (Gck+/−) diabetic mice. We challenged animals with a diet containing a combination of sucrose and oleic acid (SO) or sucrose and linoleic acid (SL). Next, we assessed the effects of a DPP-4 inhibitor, des-fluoro-sitagliptin, on adipose tissue inflammation and hepatic steatosis. RESULTS: The epididymal fat weight and serum leptin level were significantly higher in Gck+/− mice fed SL than in mice fed SO, although no significant differences in body weight or adipocyte size were noted. Compared with SO, SL increased the numbers of CD11c+ M1 macrophages and CD8+ T-cells in visceral adipose tissue and the expression of E-selectin, P-selectin, and plasminogen activator inhibitor-1 (PAI-1). DPP-4 inhibition significantly prevented adipose tissue infiltration by CD8+ T-cells and M1 macrophages and decreased the expression of PAI-1. The production of cytokines by activated T-cells was not affected by DPP-4 inhibition. Furthermore, DPP-4 inhibition prevented fatty liver in both wild-type and Gck+/− mice. DPP-4 inhibition also decreased the expressions of sterol regulatory element–binding protein-1c, stearoyl-CoA desaturase-1, and fatty acid synthase, and increased the expression of peroxisome proliferator–activated receptor-α in the liver. CONCLUSIONS: Our findings indicated that DPP-4 inhibition has extrapancreatic protective effects against diet-induced adipose tissue inflammation and hepatic steatosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies in mice reported a reduction in liver TG and histologic grade of hepatic steatosis with sitagliptin [183] but if this is a direct or indirect effect is uncertain.”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [183]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Treatment of Huh7 and HepG2 hepatoma cells with exenatide decreased intracellular lipid accumulation [181,182] by enhancing fatty acid oxidation and reducing lipogenesis [160,161,179,183].”
From Gut-pancreas-liver Axis as a target for treatment of NAFLD/NASH (2020) · cites this paper as [183]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664 · cited 1×
“A phenotypic switch of ATMs from an anti-inflammatory M2 polarization state to a proinflammatory M1 polarization state is thought to be responsible for the inflammatory changes in the adipose tissue (21,24).”
BackgroundCinti, S., Mitchell, G., Barbatelli, G., Murano, I., Ceresi, E., Faloia, E., Wang, S., Fortier, M., Greenberg, A. S., & Obin, M. S. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500294-jlr200 · Cited by 2,529
Nishimura, S., Manabe, I., Nagasaki, M., Eto, K., Yamashita, H., Ohsugi, M., Otsu, M., Hara, K., Ueki, K., Sugiura, S., et al. (2009) · Nature Medicine · doi:10.1038/nm.1964 · Cited by 2,230
Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C., Bremer, A. A., Graham, J. L., Hatcher, B., Cox, C. L., Dyachenko, A., Zhang, W., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37385 · Cited by 1,765
Hodson, L., Skeaff, C. M., & Fielding, B. A. (2008) · Progress in Lipid Research · doi:10.1016/j.plipres.2008.03.003 · Cited by 1,309
The Opposing Effects of N-3 and n-6 Fatty Acids
Schmitz, G., & Ecker, J. (2008) · Progress in Lipid Research · doi:10.1016/j.plipres.2007.12.004 · Cited by 1,245 · cited 1×
“Linoleic acid is converted to arachidonic acid in vivo, and arachidonic acid is converted to prostaglandins, leukotrienes, and other lipid mediators by lipoxygenase or cyclooxygenase (38).”
BackgroundXu, G., Stoffers, D. A., Habener, J. F., & Bonner-Weir, S. (1999) · Diabetes · doi:10.2337/diabetes.48.12.2270 · Cited by 1,209
Advances in Male Contraception
Page, S. T., Amory, J. K., & Bremner, W. J. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0041 · Cited by 1,134
Glucolipotoxicity: fuel excess and β-cell dysfunction
Poitout, V., & Robertson, R. P. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0023 · Cited by 1,092 · cited 1×
“The combination of high levels of dietary sugars and fatty acids causes metabolic abnormalities in multiple organs (1,2).”
BackgroundInhibition of gastric inhibitory polypeptide signaling prevents obesity
Miyawaki, K., Yamada, Y., Ban, N., Ihara, Y., Tsukiyama, K., Zhou, H., Fujimoto, S., Oku, A., Tsuda, K., Toyokuni, S., et al. (2002) · Nature Medicine · doi:10.1038/nm727 · Cited by 963 · cited 1×
“Because GIP receptor-deficient mice had a lower weight and a lower adiposity (43), it seems unlikely that the increase in active GIP arising from the inhibition of DPP-4 caused a reduction in visceral fat.”
Background
Cited by
Items 201–245 of 245
The incretin system in type 2 diabetes mellitus: cardiovascular effects
Sukhareva, O. Y., Шмушкович, И. А., Shestakova, E. A., & Shestakova, M. V. (2013) · Problems of Endocrinology · doi:10.14341/probl201258633-42 · Cited by 6
Pathak, R., Kumar, A., Palfrey, H. A., Forney, L. A., Stone, K. P., Raju, N. R., Gettys, T. W., & Murthy, S. N. (2019) · Inflammation Research · doi:10.1007/s00011-019-01243-x · Cited by 4
Höfling, C., Donkersloot, P., Ulrich, L., Burghardt, S., Opitz, M., Geißler, S., Schilling, S., Cynis, H., Michalski, D., & Roßner, S. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106671 · Cited by 4
Liraglutide prevents body and fat mass gain in ovariectomized Wistar rats
Rossetti, C. L., Andrade, I. S., Boa, L. F. F., Neves, M. B., Fassarella, L. B., Bertasso, I. M., de Souza, M. D. G. C., Bouskela, E., Lisboa, P. C., Takyia, C. M., et al. (2024) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2024.112374 · Cited by 3
Pathak, R., Kumar, A., Palfrey, H. A., Stone, K. P., Raju, N. R., Gettys, T. W., & Murthy, S. N. (2022) · Inflammation Research · doi:10.1007/s00011-022-01572-4 · Cited by 3
Mathai, P., Nayak, N., Rao, M., Bhat, G., Vinodraj, K., Chandralekha, N., Rajesh, D., & Chethan, T. (2015) · International Journal of Basic & Clinical Pharmacology · doi:10.5455/2319-2003.ijbcp20150209 · Cited by 4
Aramaki, M. (2013) · Clinical Lipidology · doi:10.2217/clp.13.46 · Cited by 3
Eid, N. M. S., Albadri, A.-R., Alshobragi, K., Sharqawi, N., Albar, R., & Altaf, A. (2018) · Journal of Food and Nutrition Research · doi:10.12691/jfnr-6-3-1 · Cited by 3
Stepanov, Y. М., Абатуров, А. Е., Zavgorodnia, N. Y., & Skyrda, І. Y. (2020) · GASTROENTEROLOGY · doi:10.22141/2308-2097.2.56.2015.81504 · Cited by 7
Barkondaj, B., Nargis, T., Chakrabarti, P., Mukhopadhyay, S., Biswas, K., Ganguly, D., Chaterjee, C., Sengupta, N., & Hazra, A. (2022) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_139_22 · Cited by 2
Jawad, A. N., Kadhim, K. A., Alzajaji, Q. B., & Al-Neshmi, H. (2024) · Al Mustansiriyah Journal of Pharmaceutical Sciences · doi:10.32947/ajps.v24i3.1082 · Cited by 2
Meng, X., Cai, L., Ren, T., Sun, D. S., & Gu, J. (2018) · Analytical Methods · doi:10.1039/c8ay00040a · Cited by 2
Inflammation of adipose tissue (Part 6). The effects of medicamental preparations
Шварц, В. Я. (2012) · Problems of Endocrinology · doi:10.14341/probl201258167-73 · Cited by 3
HEBAT ALLAH M. MAHMOUD, M. S. ;. F. A. M., HASHEM, M. D. H. H. A. G., & Mahmoud, H. (2018) · The Medical Journal of Cairo University/The Medical Journal of Cairo University · doi:10.21608/mjcu.2018.55786 · Cited by 2
Li, Y., Xiao, J., Xu, L., Pei, Y., Han, X., Li, C., & Tian, H. (2020) · Journal of International Medical Research · doi:10.1177/0300060520934635 · Cited by 4
AKTAŞ, A., & Ozan, Z. T. (2020) · Cumhuriyet Tıp Dergisi/Cumhuriyet Üniversitesi Tıp Fakültesi dergisi · doi:10.7197/cmj.835387 · Cited by 2
Yang, F., Dang, S., Lv, H., & Shi, B. (2021) · Journal of International Medical Research · doi:10.1177/0300060520985664 · Cited by 2
Identification of effect modifiers using a stratified Mendelian randomization algorithmic framework
Man, A., Knüsel, L., Graf, J., Lali, R., Le, A., Scipio, M. D., Mohammadi‐Shemirani, P., Chong, M., Pigeyre, M., Kutalik, Z., et al. (2025) · European Journal of Epidemiology · doi:10.1007/s10654-025-01213-0 · Cited by 5
Do, D. V., Nguyen, G., Park, S. Y., & Cho, E.-H. (2025) · Journal of Korean Medical Science · doi:10.3346/jkms.2025.40.e304 · Cited by 1
Fu, Y., Masuda, T., Eguchi, A., Czogalla, J., Rose, M. A., Kuczkowski, A., Gerasimova, M., Feldstein, A. E., Scadeng, M., & Vallon, V. (2014) · The FASEB Journal · doi:10.1096/fasebj.28.1_supplement.1160.9 · Cited by 1
Pro-oncogenic role of SerpinB3 in hepatocellular carcinoma
Martini, A., & Pontisso, P. (2018) · Hepatoma Research · doi:10.20517/2394-5079.2018.50 · Cited by 1
Alteration of dipeptidyl peptidase IV activity in rodents with exudative inflammation
Иванова, Е. А., Золотов, Н. Н., Pozdnev, V. F., & Воронина, Т. А. (2018) · Nauchno-prakticheskii zhurnal «Patogenez» · doi:10.25557/2310-0435.2018.01.51-57 · Cited by 3
Linagliptin Modulation of Inflammation in Chronic Coronary Artery Disease
Muir, K. C., Harris, D. D., Stone, C., Kanuparthy, M., Broadwin, M., Hamze, J., Abid, M. R., & Sellke, F. W. (2025) · Journal of Surgical Research · doi:10.1016/j.jss.2025.03.036 · Cited by 1
Elkattawy, H. A., & Ashour, W. M. R. (2019) · Al-Azhar Medical Journal · doi:10.21608/amj.2019.56675 · Cited by 1
Mulder, D. J., Heerspink, H. J. L., & Lefrandt, J. D. (2012) · Nederlands Tijdschrift voor Diabetologie · doi:10.1007/s12467-012-0002-6
Glucagon-like peptide-1 in nonalcoholic steatohepatitis
Armstrong, M. J. (2014) · University of Birmingham Institutional Research Archive (University of Birmingham)
The role of gliptins on adipogenesis
Estrada, M. F. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Effect of DPP-4 Inhibitors on the Cardiovascular System, Cancer and Pancreatitis
Cho, E.-H. (2013) · Journal of Korean Diabetes · doi:10.4093/jkd.2013.14.3.138
Sell, H., Bl, M., Schlich, R., Willems, M., Ruppe, F., Knoefel, W. T., Dietrich, A., Fielding, B. A., Arner, P., Frayn, K. N., et al. (2013)
Impact of insulin resistance on hepatocellular carcinoma
Kawaguchi, T., & Torimura, T. (2015) · Kanzo · doi:10.2957/kanzo.56.127
Extrapancreatic contribution to glucose regulation by dipeptidyl peptidase 4 inhibition
Omar, B. A., & Åhrén, B. (2016) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000088
Molecular antagonists, leptin or other hormones in supplementing environmental factors?
Hazlehurst, J., & Tomlinson, J. (2016) · Wiley eBooks · doi:10.1002/9781118924938.ch24
Targeting obesity-related inflammation through nutritional and genetic approaches
LeMieux, M. J. (2015) · ThinkTech (Texas Tech University)
The Role of p21-activated Protein Kinase 1 in Metabolic Homeostasis
Chiang, Y. P. (2014) · TSpace (University of Toronto)
Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease (NAFLD) in Type 2 Diabetes
Cusi, K. J. (2017) · Contemporary diabetes · doi:10.1007/978-3-319-61013-9_4
Fülöp, G. Á., Dezső, L., & Wittmann, I. (2019) · Diabetologia Hungarica · doi:10.24121/dh.2019.4
Metabolic effects of dipeptyl peptidase 4 inhibitor in type 2 diabetes
Macauley, M. (2016)
Cusi, K. J. (2011) · Endocrine Practice · doi:10.1016/s1530-891x(20)43146-5
The pathophysiology of gut–liver connection
Maroni, L., Fianchi, F., Miele, L., & Svegliati‐Baroni, G. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821927-0.00002-4
Heeba, G. H., Abolnaga, M., & Othman, E. M. (2023) · Bulletin of Pharmaceutical Sciences Assiut · doi:10.21608/bfsa.2023.301257
Pelluri, R., Kongara, S., Nagasubramanian, V. R., Mahadevan, S., & Chimakurthy, J. (2024) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2023.0218 · Cited by 1
Huang, J., Tong, X. L., Xiang, M. S. W., Boumelhem, B. B., Foulis, D. P., Zhang, M., McKenzie, C. A., McCaughan, G. W., Reinheckel, T., Zhang, H. E., et al. (2024) · Preprints.org · doi:10.20944/preprints202403.1824.v1
Barkondaj, B., Chakrabarti, P., Mukhopadhyay, S., Ganguly, D., Sengupta, N., Chatterjee, C., Hazra, A., & Bose, C. (2026) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_397_25
Proteostasis in the regulation of pancreatic islet cell plasticity
Shirakawa, J. (2026) · Journal of Diabetes Investigation · doi:10.1111/jdi.70438
Self-citation
Metadata
- Authors
- Shirakawa, J., Fujii, H., Ohnuma, K., Sato, K., Ito, Y., Kaji, M., Sakamoto, E., Koganei, M., Sasaki, H., Nagashima, Y., Amo, K., Aoki, K., Morimoto, C., Takeda, E., & Terauchi, Y.
- Affiliations
- Yokohama City University (JP)
- Keio University (JP)
- Institute of Medical Science, The University of Tokyo (JP)
- Meiji (Japan) (JP)
- Tokushima University (JP)
- Corresponding author
- Terauchi, Yasuo
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2011-03-22
- Volume
- 60
- Issue
- 4
- Pages
- 1246-1257
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3064098
- OpenAlex
- W2102849202
- Cited by
- 246
- References
- 49
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 8 · 2023: 5 · 2022: 11 · 2021: 16 · 2020: 11 · 2019: 13 · 2018: 27 · 2017: 10 · 2016: 26 · 2015: 23 · 2014: 31 · 2013: 29 · 2012: 21
- FWCI
- 21.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (23591315, 22650223, 22590437, 21300277, 22390200)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Keywords
- DPP-4 inhibition, adipose tissue inflammation, hepatic steatosis, diet-induced obesity, visceral adipose tissue, M1 macrophages, CD8+ T cells, plasminogen activator inhibitor-1, fatty acid synthase, stearoyl-CoA desaturase 1, SREBP-1c, PPARα, linoleic acid, oleic acid, sucrose, leptin
- MeSH terms
- Exenatide, Adipose Tissue, Animals, Blood Glucose, Body Weight, Dietary Fats, Enzyme-Linked Immunosorbent Assay, Fatty Liver, Female, Glucokinase, Hypertrophy, Insulin, Interferon-gamma, Liver, Male, Peptides, Triglycerides, Tumor Necrosis Factor-alpha, Venoms, Polymerase Chain Reaction, Interleukin-10, Dipeptidyl Peptidase 4, Chemokine CCL2, Dietary Sucrose, Mice, Dipeptidyl-Peptidase IV Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.